We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Variations in the BRAF Gene Linked to Melanoma Risk

By Biotechdaily staff writers
Posted on 08 Dec 2003
Cancer researchers in Germany have identified a variable gene that in men is associated with an increased risk of developing skin cancer, specifically melanoma.

Investigators at Tuebingen University Hospital (Germany) obtained blood samples from 450 healthy volunteers and from 500 melanoma patients. More...
The samples were screened for genetic variation across more than 25,000 sites. Results of the study, published in the November 2003 issue of the Journal of Carcinogenesis, revealed that the BRAF gene, which encodes a protein involved in cell growth and multiplication, was found more often in men with melanoma than in the general population or in women with melanoma.

Since men have a one in 58 chance and women a one in 82 chance of developing malignant melanoma during their lifetime, it was postulated that BRAF may be one explanation of why males have an increased lifetime incidence of melanoma compared to females.

Senior author Professor Claus Garbe from Tuebingen University Hospital explained, "Moles are a major risk factor for the development of malignant melanoma. BRAF mutations occur in the majority of melanomas but also in moles. We are therefore interested in addressing the question of whether carrying certain variants of the BRAF gene could predispose people to having or developing more moles, and thus to an increased risk of developing melanoma.”





Related Links:
Tuebingen University Hospital

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
Manual Pipetting Aid
Pipette Controllers macro
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.